Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 1
2000 1
2001 3
2002 2
2003 5
2004 5
2005 2
2006 2
2007 4
2008 4
2009 4
2010 7
2011 8
2012 11
2013 6
2014 2
2015 1
2016 3
2017 2
2019 1
2020 3
2021 9
2022 1
2023 3
2024 3
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

80 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis.
Kowdley KV, Bowlus CL, Levy C, Akarca US, Alvares-da-Silva MR, Andreone P, Arrese M, Corpechot C, Francque SM, Heneghan MA, Invernizzi P, Jones D, Kruger FC, Lawitz E, Mayo MJ, Shiffman ML, Swain MG, Valera JM, Vargas V, Vierling JM, Villamil A, Addy C, Dietrich J, Germain JM, Mazain S, Rafailovic D, Taddé B, Miller B, Shu J, Zein CO, Schattenberg JM; ELATIVE Study Investigators’ Group; ELATIVE Study Investigators' Group. Kowdley KV, et al. Among authors: zein co. N Engl J Med. 2024 Feb 29;390(9):795-805. doi: 10.1056/NEJMoa2306185. Epub 2023 Nov 13. N Engl J Med. 2024. PMID: 37962077 Clinical Trial.
Primary sclerosing cholangitis.
Zein CO. Zein CO. Clin Liver Dis. 2013 May;17(2):211-27. doi: 10.1016/j.cld.2012.11.003. Epub 2012 Dec 20. Clin Liver Dis. 2013. PMID: 23540498 Review.
Safety and efficacy of elafibranor in primary sclerosing cholangitis: The ELMWOOD phase II randomized-controlled trial.
Levy C, Abouda GF, Bilir BM, Bonder A, Bowlus CL, Campos-Varela I, Cazzagon N, Chandok N, Cheent K, Cortez-Pinto H, Demir M, Dill MT, Eksteen B, Fenkel JM, Gilroy R, Ko HH, Jacobson IM, Kallis Y, Kugelmas M, Luketic V, Mangia A, Montano-Loza AJ, Mukhopadhya A, Olveira A, Patel BC, Pietrangelo A, Pradhan F, Salcedo M, Shiffman ML, Sprinzl K, Swann R, Thorburn D, Thuluvath PJ, Trivedi PJ, Turnes J, Zein CO, Gomes da Silva H, Jaitly S, Miller B, Milligan C, Tavenard A, Kowdley KV. Levy C, et al. Among authors: zein co. J Hepatol. 2025 May 8:S0168-8278(25)00252-1. doi: 10.1016/j.jhep.2025.04.025. Online ahead of print. J Hepatol. 2025. PMID: 40350321 Free article.
Advances in therapy for hepatitis C infection.
Zein CO, Zein NN. Zein CO, et al. Microbes Infect. 2002 Oct;4(12):1237-46. doi: 10.1016/s1286-4579(02)01651-9. Microbes Infect. 2002. PMID: 12467765 Free article. Review.
Aortic root aneurysm repair in a neonate with Loeys-Dietz syndrome.
Li W, Cohen W, Combs P, Wong J, Loomba R, Lee BK, El-Zein C, Ilbawi M, Vricella L, Hibino N. Li W, et al. Among authors: el zein c. Cardiol Young. 2021 May;31(5):848-850. doi: 10.1017/S1047951120004886. Epub 2021 Jan 25. Cardiol Young. 2021. PMID: 33487195
80 results